Overview


According to FutureWise analysis the market for insulin pumps in 2023 is US$ 5.36 billion, and is expected to reach US$ 18.07 billion by 2031 at a CAGR of 16.42%.

Insulin Pumps are discreet, electronic medical devices that can be carried on a belt or concealed under clothes. The insulin pump delivers insulin to the body regularly to prevent an increase in blood glucose levels based on the user's basal and bolus rates. The primary drivers of market expansion are the rising incidence of diabetes globally and rising health consciousness. The modernization of the economy has significantly increased the prevalence of several diseases linked to a sedentary lifestyle, including diabetes. Changes in dietary preferences and reliance on prepared packaged meals with artificial substances and preservatives also produce a positive impact. The demand for efficient Insulin Pumps has increased due to the development of very accurate glucose sensors and blood monitoring technology.

Technological developments and the growing preference for insulin pumps over traditional approaches are some of the factors impacting market expansion. For individuals who need several insulin injections each day, insulin pumps are quite practical. Due to their reduced invasiveness, the patient population has largely adopted these devices. The rising elderly population, rising incidence of diabetes, and rising prevalence of obesity are the main factors responsible for the market's expansion. In addition, companies are creating next-generation insulin pumps with cutting-edge technology to offer improved compliance and integration with IT devices, which is helping the market expand. In the near future, it is also projected that technological advancements such as home infusion therapy and artificial pancreas will generate major growth potential. Additionally, growing public knowledge of insulin pumps and their use has fueled market expansion in both developed and developing nations.

FutureWise Market Research has published a report that provides an insightful analysis of insulin pumps market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the insulin pumps market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Hoffmann-La Roche AG.
  • Ypsomed AG
  • Medtronic
  • Insulet Corporation
  • B Braun Melsungen AG
  • Abbott Laboratories
  • Becton, Dickinson And Company
  • Sanofi
  • Animus Corp.
  • Asante
  • Nipro Diagnostics Inc.
  • Tandem Diabetes Care Inc.
  • Sooil Development Co.Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Diabetes is a major health problem that affects both developed and developing countries equally, detrimental to the economy and society. Diabetes affects 347 million people globally. The World Health Organisation predicts that by 2030, it will rank as the seventh most common cause of death. The market's expansion is mostly attributed to the rising elderly population, rising diabetes incidence, and rising obesity prevalence. Moreover, the use of insulin pumps in the management of type 1 diabetes has been facilitated by rapid technological advancement, efficacy as demonstrated by clinical trials and scientific reports, cost-effectiveness encouraging reimbursement by healthcare systems, acceptance by patients in their daily lives, and support from healthcare professionals. Insulin pump technology has advanced rapidly to more closely mimic physiological insulin production, aid patients in obtaining tight glycemic control while lowering the risk of hypoglycemia, and support them in doing so. Additionally, the integration of insulin pumps with continuous glucose monitoring (CGM) systems has significantly widened the market for insulin pumps with "smarter" insulin pumps that suspend insulin for hypoglycemia or even automate some insulin delivery, all intending to help individuals meet glycemic targets with less effort. Key market players are expected to benefit from technological advancement in the insulin pump market. However, the widespread adoption of insulin pumps is being hampered by their high price. The lack of understanding about diabetes treatment options, particularly in developing nations, also hinders market expansion. The inadequate reimbursement practices in undeveloped countries limits the usage of insulin pumps globally.

By Type

  • Patch Pump
  • Tethered Pump

By End User

  • Hospitals and Clinics
  • Homecare
  • Laboratories

By Product Type

  • MiniMed (630G, 670G, and VEO)
  • Accu-Chek (Combo, Insight, and Solo)
  • Tandem (T: slim X2, G4, T: flex Delivery System)
  • Omnipod
  • My Life Omnipod
  • Others

By Accessories

  • Insulin Reservoir
  • Insulin Set Insertion Devices
  • Battery

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022, due to the existence of significant insulin pump manufacturers. Additionally, it is anticipated that the market in the region will be driven by the rising incidence of obesity, high treatment costs, technological advancements, and new releases. Due to a rise in the geriatric individuals who are more susceptible to diabetes, the region's increased demand for insulin pumps is fueled by advancements in its healthcare system and the use of cutting-edge medical products.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Insulin Pumps Market By Type, By End User, By Product Type, By Accessories and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customisations offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Insulin Pumps Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Product Of Administration Overview
        6. Dermatology Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Insulin Pumps Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Dermatology Framework
  • 6.   Global Insulin Pumps Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. End User Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. End User Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Insulin Pumps Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Patch Pump
        2. Tethered Pump

  • 8.   Global Insulin Pumps Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Clinics
        2. Homecare
        3. Laboratories

  • 9.   Global Insulin Pumps Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. MiniMed (630G, 670G, and VEO)
        2. Accu-Chek (Combo, Insight, and Solo)
        3. Tandem (T: slim X2, G4, T: flex Delivery System)
        4. Omnipod
        5. My Life Omnipod
        6. Others

  • 10.   Global Insulin Pumps Market, By Accessories Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Insulin Reservoir
        2. Insulin Set Insertion Devices
        3. Battery

  • 11.   North America Insulin Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Insulin Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Insulin Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Insulin Pumps Market Analysis 2017-2022 and Forecast 2023-2031(USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hoffmann-La Roche AG.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Ypsomed AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Insulet Corporation
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. B Braun Melsungen AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Abbott Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton, Dickinson and Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Sanofi
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Animus Corp.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Asante
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Nipro Diagnostic Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Tandem Diabetes Care Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Sooil Development Co.Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the Medical industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the Medical regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients